The first integrated incision & drainage device that reduces procedure time from 30–60 minutes to under 10 minutes. Faster, safer, and cleaner abscess care — finally.
The Problem
Manual manipulation causes significant discomfort. Rated the 2nd most painful ED procedure, with no standardized approach to reduce it.
Clinicians juggle 3–5+ separate instruments. This ties up an ER bed and provider for nearly an hour — slowing care for all other patients.
Uncontrolled drainage creates multiple contamination touchpoints, increasing exposure risk for providers and extending cleanup time.
1.5M ED cases × 45 min average = 1.1 million hours of lost provider capacity annually. High-value time wasted on a low-complexity inefficiency.
The Solution
One sterile instrument. Incision, evacuation, and drainage — seamlessly unified. Providers complete the entire I&D process in under 3 minutes, a transformational leap over traditional technique.
Combines incision, evacuation, and drainage management into one ergonomic system — eliminating instrument exchanges and reducing procedure time from 30–60 min to under 10 min.
Integrated aspiration system provides controlled, directed drainage. Reduces manual wound manipulation and delivers consistent, standardized outcomes across provider skill levels.
Enclosed design minimizes splatter and contamination risk. Fewer exposure touchpoints for providers, reduced PPE requirements, and faster, cleaner room turnover.
Greatly reduced procedural pain and duration. Physician-invented by an EM physician who experienced the procedure as a patient — designed with clinical empathy at its core.
Returns valuable provider time to the floor, reduces staffing pressure, lowers inventory requirements for packing materials, excess PPE, syringes, gauze, and anesthetics.
Bench testing completed using modeled abscess material confirming ergonomics and evacuation efficiency. 20+ physician interviews with overwhelmingly positive feedback.
Market Opportunity
Only 1% market penetration yields $300,000–$750,000 in annual revenue. Expansion pathways include Outpatient Surgery, OB/GYN Offices, and Wound Care Centers. Strategic distribution through Medline, McKesson, Henry Schein, and Cardinal Health.
Team & Advisors
Emergency Medicine Physician and MedTech innovator performing I&D procedures daily on the frontline. Published researcher. Conceived InDeazy as both patient and physician — a perspective that drives every design decision.
10+ years in Project Management & Operations. Experienced across full product development lifecycles and strategic execution. Leads regulatory strategy, investor relations, and commercialization operations for Bromley Bio Med LLC.
Advisory Board
InDeazy™ is backed by a multidisciplinary advisory board bringing deep expertise across the full spectrum of medical device development and healthcare delivery. Our advisors include emergency medicine physicians, an accelerator program manager, a biomedical engineer, wound care specialists, regulatory consultants, and clinical specialists — providing guidance across clinical validation, regulatory strategy, commercialization, and operational execution.
Execution Roadmap
The Ask & Use of Funds
Pre-Seed Round · Currently Targeting $125K
Capital deployed to de-risk regulatory pathway and secure initial clinical pilot sites. Projected gross margins above 90% with a clear path to strategic acquisition.
Get In Touch
Return time back to efficient care. We're actively speaking with investors, strategic partners, and clinical collaborators.
"I've performed this procedure hundreds of times — and I've felt the pain as a patient and mother. I built InDeazy™ because patients deserve a better experience and providers need a faster, safer workflow."
— Dr. Alexis Bromley, MD, MBS